Management of chronic lymphocytic leukemia: a changing field.
Keating
Michael J
MJ
Department of Leukemia, University of Texas, M.D. Anderson Cancer Center, Houston 77030, USA. mkeating@mdanderson.org
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000494:pharmacology; D019468:Disease Management; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy* / Q000401:mortality / Q000628:therapy; D011687:Purines / Q000627:therapeutic use; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D011687:Purines